Ian Morrissey

Ian Morrissey is a prominent figure in the field of antimicrobial research and development. He currently serves as the Chief Scientific & Development Officer at IHMA Europe Sàrl, a company based in Switzerland that specializes in antimicrobial drug development services.12

Professional Background

Dr. Morrissey has over 30 years of experience in research and development related to new antimicrobial agents.4 His career path includes:

• Founder of Antimicrobial Focus Ltd., a consultancy firm supporting biotech and pharmaceutical companies in antimicrobial development45
• Chief Scientific & Development Officer at IHMA Europe (2018-present)56
• Director of New Business and Project Development for Europe, Middle East and Asia at IHMA (2012-2018)56
• Director of Microbiology at a previous organization5

Expertise and Contributions

Dr. Morrissey is highly regarded in his field:

• Voting member of the Clinical Laboratory Standards Institute (CLSI) veterinary antimicrobial susceptibility standards subcommittee1
• Fellow of the Royal Society of Medicine1
• Former General Secretary and Chairman of the Grants Committee for the British Society for Antimicrobial Chemotherapy (BSAC)1
• Author of over 100 peer-reviewed manuscripts and ten books or book chapters1

Education

Ian Morrissey holds impressive academic credentials:

• Doctorate from the University of London, UK (1990)1
• Executive MBA from Imperial College London, UK (2001)1

In his current role at IHMA Europe, Dr. Morrissey is involved in various initiatives, including the development of new antifungal surveillance programs like the Analysis of Resistance to Antifungals (ARIA).3 His expertise continues to contribute significantly to the field of antimicrobial research and development.